Lecture provided by:
Dr. Milan Gupta
Doctor’s Bio
Dr. Milan Gupta an Associate Clinical Professor of Medicine at McMaster University in Hamilton, Canada. He has over100 peer-reviewed manuscripts. He serves on numerous professional advisory boards and guidelines writing committees. Dr. Gupta is the medical director of the Canadian Collaborative Research Network and a past executive member of the Canadian Cardiovascular Society. He is co-founder and past chair of the Greater Toronto Area Community Cardiologists (GTACC) and chairs the Board of Directors of SANSAR (www.sansar.org), a national charitable organization whose mission is to reduce the burden of cardiovascular disease in South Asians.
Addressing Residual Risk Beyond LDL-Cholesterol
Takeaways from the course:
- To review the concept of persistent cardiovascular risk in high-risk patients on statin therapy
- Statin agents I used to reduce cardiovascular risk, however, the concept of whether there is a persistent residual risk beyond LDL lowering would be explored.
- To explore the role of serum triglycerides as a marker of risk
- Typically, LDL cholesterol is used as a marker of assessing cardiovascular risk. His presentation explores whether serum triglycerides also serve as a marker for cardiovascular risk.
- To discuss the practical applications of icosapent ethyl for CV risk reduction
Upcoming Lectures
February Lecture: Secure Messaging in the Post-pandemic World (Dr. Duncan Rozario)
Lecture provided by: Dr. Duncan Rozario,
November Lecture: Update on the 2021 lipid guidelines (Dr. Gupta)
Lecture provided by:Dr. Milan Gupta Doctor’s
January Lecture: Parkinson’s Disease Update on Diagnosis and Management (Dr. Susan Fox)
Lecture provided by: Dr. Susan Fox
